Cargando…
Prognostic factors of successful on-purpose tumor biopsies in metastatic cancer patients included in the SHIVA prospective clinical trial
PURPOSE: To identify patient/tumor characteristics associated with success of biopsy in patients who received multiple lines of chemotherapy. METHODS: Patients with refractory cancer from our center, who were included in a prospective randomized phase II trial comparing targeted therapies based on m...
Autores principales: | Desportes, Emilie, Wagner, Mathilde, Kamal, Maud, Salomon, Anne Vincent, Deniziaut, Gabrielle, Pierron, Gaëlle, Rouleau, Etienne, Jouffroy, Thomas, Le Tourneau, Christophe, Paoletti, Xavier, Servois, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352095/ https://www.ncbi.nlm.nih.gov/pubmed/27655703 http://dx.doi.org/10.18632/oncotarget.12051 |
Ejemplares similares
-
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial
por: Basse, Clémence, et al.
Publicado: (2018) -
Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial
por: Dupain, Célia, et al.
Publicado: (2020) -
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
por: Petak, Istvan, et al.
Publicado: (2021) -
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
por: Le Tourneau, C, et al.
Publicado: (2014) -
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2015)